Ontology highlight
ABSTRACT: Background
Brain metastases (BM) cause relevant morbidity and mortality in cancer patients. The presence of cerebrovascular diseases can alter the tumor microenvironment, cellular proliferation and treatment resistance. However, it is largely unknown if the presence of distinct cerebrovascular risk factors may alter the prognosis of patients with BM.Methods
Patients admitted for the radiotherapy of BM at a large tertiary cancer center were included. Patient and survival data, including cerebrovascular risk factors (diabetes mellitus (DM), smoking, arterial hypertension, peripheral arterial occlusive disease, hypercholesterolemia and smoking) were recorded.Results
203 patients were included. Patients with DM (n = 39) had significantly shorter overall survival (OS) (HR 1.75 (1.20-2.56), p = 0.003, log-rank). Other vascular comorbidities were not associated with differences in OS. DM remained prognostically significant in the multivariate Cox regression including established prognostic factors (HR 1.92 (1.20-3.06), p = 0.006). Furthermore, subgroup analyses revealed a prognostic role of DM in patients with non-small cell lung cancer, both in univariate (HR 1.68 (0.97-2.93), p = 0.066) and multivariate analysis (HR 2.73 (1.33-5.63), p = 0.006), and a trend in melanoma patients.Conclusion
DM is associated with reduced survival in patients with BM. Further research is necessary to better understand the molecular mechanisms and therapeutic implications of this important interaction.
SUBMITTER: Jeong S
PROVIDER: S-EPMC10571851 | biostudies-literature | 2023 Oct
REPOSITORIES: biostudies-literature
Jeong Seong S Poudyal Soniya S Klagges Sabine S Kuhnt Thomas T Papsdorf Kirsten K Hambsch Peter P Wach Johannes J Güresir Erdem E Nägler Franziska F Rühle Alexander A Nicolay Nils H NH Seidel Clemens C
Cancers 20231004 19
<h4>Background</h4>Brain metastases (BM) cause relevant morbidity and mortality in cancer patients. The presence of cerebrovascular diseases can alter the tumor microenvironment, cellular proliferation and treatment resistance. However, it is largely unknown if the presence of distinct cerebrovascular risk factors may alter the prognosis of patients with BM.<h4>Methods</h4>Patients admitted for the radiotherapy of BM at a large tertiary cancer center were included. Patient and survival data, inc ...[more]